BOOTHBAY FUND MANAGEMENT, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$95,000
+2.2%
116,8620.0%0.00%0.0%
Q4 2021$93,000
-33.1%
116,8620.0%0.00%
-50.0%
Q3 2021$139,000
-51.7%
116,862
-37.2%
0.00%
-55.6%
Q2 2021$288,000
-26.0%
185,988
+14.8%
0.01%
-40.0%
Q1 2021$389,000
-18.6%
161,9490.0%0.02%
-16.7%
Q4 2020$478,000
+58.8%
161,949
-17.6%
0.02%0.0%
Q3 2020$301,000
-13.5%
196,653
+41.3%
0.02%
-25.0%
Q2 2020$348,000
+22.5%
139,1830.0%0.02%0.0%
Q1 2020$284,000139,1830.02%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders